Vanda Pharmaceuticals Inc.
$321.69M- Market cap
- $328.31M
- Debt
- +$78.23M
- Cash
- −$84.85M
Capital structure 81% equity / 19% debt · EV / Revenue 1.49x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
VNDA · current priceP/S 1.52x
$5.43Latest market snapshot
Implied fair value · at BNTX's multiple
$27.93414.4% above market
3.57 VNDA revenue / share×7.81x BNTX P/S=$27.93
Market $5.43Implied $27.93
BNTX · current priceP/S 7.81x
$103.76Latest market snapshot
Implied fair value · at VNDA's multiple
$20.1780.6% below market
13.28 BNTX revenue / share×1.52x VNDA P/S=$20.17
Market $103.76Implied $20.17